Home News Company News
2026.02.11
Medconn Diagnostics Makes a Strong Start at WHX Dubai 2026

 

Medconn Brings New Diagnostic Solutions to WHX Dubai

As one of the world's leading healthcare events, WHX Dubai brings together healthcare professionals, industry leaders, and medical innovators from around the globe. For Medconn, the event represents more than a product showcase—it is an ongoing platform for international dialogue, collaboration, and exchange.

In 2026, Medconn returned to WHX Dubai with new technologies, products, and diagnostic solutions, continuing its commitment to advancing accessible and practical diagnostic solutions for healthcare professionals worldwide.

 

Returning to the Global Stage — Building Trust Through Long-Term Engagement

On February 10, Medconn once again participated in WHX Dubai. As a long-standing participant in the international exhibition, Medconn has maintained an active presence at the event for several consecutive years, engaging face-to-face with partners from the Middle East, Africa, Europe, and South Asia.

This year, the Medconn booth welcomed a steady stream of visitors and generated extensive discussions, ranging from product capabilities to real-world clinical applications. Years of continued participation have enabled more efficient conversations with international partners while reinforcing Medconn's commitment to professional expertise, product reliability, and long-term collaboration.

 

From Proven Solutions to New Breakthroughs

Alongside its established HbA1c and hematology solutions, Medconn's newly launched MI Mini90 Single-Use Chemiluminescence Immunoassay System became one of the major highlights of the exhibition.

The new system quickly attracted significant attention, with a constant flow of visitors stopping by the booth for product demonstrations, hands-on experience, consultations, and business discussions.

Medconn also presented a diverse range of diagnostic solutions, including a portable POCT blood gas analyzer, extending testing capabilities to point-of-care and on-site applications, and the MCA Series Coagulation Analyzers, which use the magnetic bead method to deliver stable and reliable results.

Different products, different application scenarios, but one shared goal: bringing diagnostic testing closer to real clinical needs.

 

 

 

Product Spotlight — MI Mini90 Single-Use Chemiluminescence Immunoassay System

 

No Liquid Handling System, Simplified Design

The MI Mini90 features innovative lyophilized microsphere technology and a completely liquid-free internal design.

Without complex tubing or daily liquid-path maintenance, the system minimizes the risks of clogging and liquid-path contamination while eliminating additional cleaning requirements and reducing routine maintenance.

 

True Whole-Blood Testing, Simple Operation

Unlike conventional chemiluminescence systems that rely on serum or plasma samples, the MI Mini90 supports direct whole-blood testing.

With a simple “one drop of blood, ready to test” workflow, the system significantly lowers the operational barrier to chemiluminescence testing and improves testing efficiency.

No centrifugation.
No serum separation.
No pipetting.
No additional filtration.

 

Product Spotlight — Portable Blood Gas Analyzer

Designed for POCT and emergency care, Medconn's new portable blood gas analyzer brings greater flexibility to blood gas testing.

Using a test-card-based testing format, the system avoids many of the maintenance requirements associated with traditional wet or semi-wet blood gas analyzers. Its compact and portable design allows blood gas testing to move beyond the laboratory into bedside, emergency, and even mobile healthcare settings.

Lightweight, rechargeable, and easy to carry, the analyzer enables testing anytime, wherever it is needed.

 

Product Spotlight — MCA-300 & MCA-020 Coagulation Analyzers

In coagulation testing, Medconn offers a comprehensive product portfolio designed to meet the needs of different laboratory settings.

Both the MCA-300 Fully Automated Coagulation Analysis System and MCA-020 Semi-Automated Coagulation Analysis System use the well-established magnetic bead detection method, helping deliver accurate and reliable results.

The testing menu covers a broad range of coagulation parameters, including the four routine tests—PT, APTT, TT, and FIB—as well as D-Dimer, vWF, Free Protein, and other specialized coagulation assays. Comprehensive quality control and calibration functions are also available to support consistent laboratory performance.

 

 

 

Moving Forward — Building Global Diagnostic Capabilities

From its continued participation in WHX Dubai to the development of diagnostic solutions designed around real-world clinical needs, Medconn is steadily strengthening its global presence through consistent innovation, technical expertise, and long-term commitment.

For Medconn, international exhibitions are not simply opportunities to showcase products. They are platforms for building relationships, understanding clinical needs, and creating long-term value.

The journey continues—and Medconn is moving forward, one step at a time, toward a more connected and accessible future for global diagnostics.